Search Results - "Honest, Ndlovu"

Imaging Molecular Targets and Metabolic Pathways in Breast Cancer for Improved Clinical Management: Current Practice and Future Perspectives by Ndlovu, Honest, Lawal, Ismaheel O, Mokoala, Kgomotso M G, Sathekge, Mike M

“…Breast cancer is the most frequently diagnosed cancer and leading cause of cancer-related deaths worldwide. Timely decision-making that enables implementation…”
Get full text

[68Ga]Ga-NODAGAZOL uptake in atherosclerotic plaques correlates with the cardiovascular risk profile of patients by Ndlovu, Honest, Lawal, Ismaheel O., Popoola, Gbenga O., Brits, Bradley, Mokoala, Kgomotso M. G., Maserumule, Letjie C., Hlongwa, Khanyisile N., Mahapane, Johncy, Davis, Cindy, Sathekge, Mike M.

“…Objectives This study aimed to determine the correlation of [ 68 Ga]Ga-NODAGA ZOL uptake in atherosclerotic plaques and the cardiovascular risk profile of…”
Get full text

COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks by Kgatle, Mankgopo Magdeline, Lawal, Ismaheel Opeyemi, Mashabela, Gabriel, Boshomane, Tebatso Moshoeu Gillian, Koatale, Palesa Caroline, Mahasha, Phetole Walter, Ndlovu, Honest, Vorster, Mariza, Rodrigues, Hosana Gomes, Zeevaart, Jan Rijn, Gordon, Siamon, Moura-Alves, Pedro, Sathekge, Mike Machaba

“…The progression of coronavirus disease 2019 (COVID-19), resulting from a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, may be…”
Get full text

Imaging dysregulated calcium homeostasis in acute myocardial infarction with [68 Ga]Ga-NODAGAZOL by Ndlovu, Honest, Lawal, Ismaheel, Mokoala, Kgomotso, Maserumule, Letjie C., Hlongwa, Khanyisile N., Mahapane, Johncy, Brits, Bradley, Annor, Tyronne, Vorster, Mariza, Sathekge, Mike

Get full text

Activity quantification and dosimetry in radiopharmaceutical therapy with reference to 177Lutetium by Ramonaheng, Keamogetswe, Qebetu, Milani, Ndlovu, Honest, Swanepoel, Cecile, Smith, Liani, Mdanda, Sipho, Mdlophane, Amanda, Sathekge, Mike

“…Radiopharmaceutical therapy has been widely adopted owing primarily to the development of novel radiopharmaceuticals. To fully utilize the potential of these…”
Get full text

Detection of Neutralizing Antibodies in COVID-19 Patients from Steve Biko Academic Hospital Complex: A Pilot Study by Kgatle, Mankgopo, Chalwe, Joseph Musonda, van der Westhuizen, Donald, Xu, Shuting, Damane, Botle Precious, Mathebela, Precious, Ueckermann, Veronica, Mayaphi, Simnikiwe, Rodrigues, Hosana Gomes, Moura-Alves, Pedro, Ndlovu, Honest, Mzizi, Yonwaba, Zongo, Lusanda, Hairwadzi, Henry, Vorster, Mariza, Zeevaart, Jan Rijn, Sathekge, Mike

“…A correlation between neutralization activity after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and protection against coronavirus…”
Get full text

68Ga-PSMA-11 PET/CT Initial Staging in Black and White South African Males with ISUP Grade Group 1 and 2 Prostate Adenocarcinoma by Maserumule, Letjie C., Mokoala, Kgomotso M. G., van de Wiele, Christophe, Popoola, Gbenga, Hlongwa, Khanyisile N., Ndlovu, Honest, Maes, Alex, Vorster, Mariza, Sathekge, Mike M.

“…Prostate adenocarcinoma (PCa) is a leading cause of mortality. Black males with high-risk PCa have a poorer prognosis compared to white males. Patients with…”
Get full text

[68Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with 18F[FDG] PET Imaging by Lawal, Ismaheel O., Popoola, Gbenga O., Mahapane, Johncy, Kaufmann, Jens, Davis, Cindy, Ndlovu, Honest, Maserumule, Letjie C., Mokoala, Kgomotso M. G., Bouterfa, Hakim, Wester, Hans-Jürgen, Zeevaart, Jan Rijn, Sathekge, Mike M.

“…People living with human immunodeficiency virus (PLHIV) have excess risk of atherosclerotic cardiovascular disease (ASCVD). Arterial inflammation is the…”
Get full text

Exceptional initial response of prostate cancer lung metastases to 225Ac-PSMA: A case report by Maserumule, Letjie C., Mokoala, Kgomotso M.G., Hlongwa, Khanyi N., Ndlovu, Honest, Reed, Janet D., Ismail, Aisha, Boshomane, Tebatso M.G., Lawal, Ismaheel O., Mokgoro, Neo P., Vorster, Mariza, Bruchertseifer, Frank, Knoesen, Otto, Morgenstern, Alfred, Sathekge, Mike M.

“…Prostate cancer is the commonest non-cutaneous cancer in males and frequently metastasizes to nodal and skeletal tissues. Metastases to soft tissue viscera…”
Get full text

Imaging PARP Upregulation with [ 123 I]I-PARPi SPECT/CT in Small Cell Neuroendocrine Carcinoma by Ndlovu, Honest, Lawal, Ismaheel, Mokoala, Kgomotso, Disenyane, Dineo, Nkambule, Nonhlahla, Bassa, Sheynaz, Mzizi, Yonwaba, Bida, Meshack, Sathekge, Mike

Get full text

Low- and high-volume disease in mHSPC, from CHAARTED to PSMA-PET: An international multicenter retrospective study by Unterrainer, Lena, Hope, Thomas A., Fendler, Wolfgang P., Ndlovu, Honest, Barbato, Francesco, Sathekge, Mike, Herrmann, Ken, Czernin, Johannes, Calais, Jeremie

“…44 Background: High-volume disease (HVD) and low-volume disease (LVD) definitions are based on conventional imaging (CI = CT + bone scan (BS)) according to…”
Get full text

PET/CT and SPECT/CT for Infection in Joints and Bones: An Overview and Future Directions by Mokoala, Kgomotso M G, Ndlovu, Honest, Lawal, Ismaheel, Sathekge, Mike Machaba

“…Infections of the bones and joints, if misdiagnosed, may result in serious morbidity and even mortality. A prompt diagnosis followed by appropriate management…”
Get full text

225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings by Sathekge, Mike, Bruchertseifer, Frank, Vorster, Mariza, Lawal, Ismaheel O., Mokoala, Kgomotso, Reed, Janet, Maseremule, Letjie, Ndlovu, Honest, Hlongwa, Khanyi, Maes, Alex, Morgenstern, Alfred, Van de Wiele, Christophe

“…Purpose 225 Ac-PSMA-617 has demonstrated good anti-tumor effect as a treatment option for metastatic castration-resistant prostate cancer (mCRPC) patients. No…”
Get full text

Prognostic Value of PSMA PET/CT in Prostate Cancer by Lawal, Ismaheel O, Ndlovu, Honest, Kgatle, Mankgopo, Mokoala, Kgomotso M G, Sathekge, Mike M

“…Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein expressed in the majority of prostate cancer (PCa). PSMA has an enzymatic function…”
Get full text

Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study by Sathekge, Mike M, Lawal, Ismaheel O, Bal, Chandrasekhar, Bruchertseifer, Frank, Ballal, Sajana, Cardaci, Giuseppe, Davis, Cindy, Eiber, Mathias, Hekimsoy, Türkay, Knoesen, Otto, Kratochwil, Clemens, Lenzo, Nat P, Mahapane, Johncy, Maserumule, Letjie C, Mdlophane, Amanda H, Mokoala, Kgomotso M G, Ndlovu, Honest, Pant, Vineet, Rathke, Hendrik, Reed, Janet, Sen, Ishita B, Singh, Aviral, Sood, Ashwani, Tauber, Robert, Thakral, Parul, Yadav, Madhav Prasad, Morgenstern, Alfred

“…Actinium-225 (225Ac) prostate-specific membrane antigen (PSMA) radioligand therapy (RLT) is a novel therapy for metastatic castration-resistant prostate cancer…”
Get full text

Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer by Lawal, Ismaheel O., Morgenstern, Alfred, Vorster, Mariza, Knoesen, Otto, Mahapane, Johncy, Hlongwa, Khanyisile N., Maserumule, Letjie C., Ndlovu, Honest, Reed, Janet D., Popoola, Gbenga O., Mokoala, Kgomotso M. G., Mdlophane, Amanda, Bruchertseifer, Frank, Sathekge, Mike M.

“…Purpose Actinium-225-labeled prostate-specific membrane antigen ([ 225 Ac]Ac-PSMA-617) is safe and effective in the treatment of metastatic…”
Get full text

Activity quantification and dosimetry in radiopharmaceutical therapy with reference to 177 Lutetium by Ramonaheng, Keamogetswe, Qebetu, Milani, Ndlovu, Honest, Swanepoel, Cecile, Smith, Liani, Mdanda, Sipho, Mdlophane, Amanda, Sathekge, Mike

“…Radiopharmaceutical therapy has been widely adopted owing primarily to the development of novel radiopharmaceuticals. To fully utilize the potential of these…”
Get full text

18FF-Poly(ADP-Ribose) Polymerase Inhibitor Radiotracers for Imaging PARP Expression and Their Potential Clinical Applications in Oncology by Ndlovu, Honest, Lawal, Ismaheel O, Mdanda, Sipho, Kgatle, Mankgopo M, Mokoala, Kgomotso M G, Al-Ibraheem, Akram, Sathekge, Mike M

“…Including poly(ADP-ribose) polymerase (PARP) inhibitors in managing patients with inoperable tumors has significantly improved outcomes. The PARP inhibitors…”
Get full text

F]F-Poly Polymerase Inhibitor Radiotracers for Imaging PARP Expression and Their Potential Clinical Applications in Oncology by Ndlovu, Honest, Lawal, Ismaheel O, Mdanda, Sipho, Kgatle, Mankgopo M, Mokoala, Kgomotso M. G, Al-Ibraheem, Akram, Sathekge, Mike M

“…Including poly(ADP-ribose) polymerase (PARP) inhibitors in managing patients with inoperable tumors has significantly improved outcomes. The PARP inhibitors…”
Get full text

Prostate-specific Membrane Antigen: Alpha-labeled Radiopharmaceuticals by Ndlovu, Honest, Mokoala, Kgomotso M.G., Lawal, Ismaheel, Emmett, Louise, Sathekge, Mike M.

“…Novel prostate-specific membrane antigen (PSMA) ligands labeled with α-emitting radionuclides are sparking a growing interest in prostate cancer treatment…”
Get full text